Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

IVF Devices and Consumables Market by Product (Instruments, Accessories and Disposables, Reagents and Media), by Technology (Fresh Embryo IVF, Frozen Embryo IVF, Donor Egg IVF), by End User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2023-2032

A00720

Pages: 282

Charts: 63

Tables: 135

IVF Devices and Consumables Market Research, 2032

The global ivf devices and consumables market was valued at $2.2 billion in 2022, and is projected to reach $12 billion by 2032, growing at a CAGR of 18.4% from 2023 to 2032. The growth of the IVF devices and consumables market is driven by a rise in prevalence of infertility, technological advancements in IVF devices, and increase in trend of delayed pregnancies. For instance, according to the World Health Organization (WHO) in 2022, around 17.5% of the adult population suffer from infertility across the globe.

Key Takeaways

  • By product, the accessories and disposables segment dominated the global market in 2022.
  • By technology, the fresh embryo IVF segment dominated the global market in 2022.
  • By end user, the fertility clinics segment dominated the market in terms of revenue in 2022.
  • By region, Asia-Pacific dominated the market share in terms of revenue in 2022 and is anticipated to grow at the highest CAGR during the forecast period.

In vitro fertilization (IVF) is a comprehensive fertility treatment aimed at overcoming reproductive challenges and addressing genetic concerns. The procedure involves the retrieval of mature eggs from the ovaries, which are then fertilized with sperm in a laboratory setting. The resulting embryos are then cultured for a few days before one or more are selected and transferred into the woman's uterus to establish a pregnancy. IVF is commonly employed to treat infertility caused by various factors, offering a solution for individuals or couples struggling to conceive naturally. IVF can be classified in five separate steps, including stimulation, also called super ovulation, egg retrieval, insemination & fertilization, embryo culture and embryo transfer. IVF devices and consumables include the products such as instruments, accessory & disposable, and reagent & media for the procedure.

Market Dynamics

The global IVF devices and consumables market is driven by increase in prevalence of infertility issues, growing awareness about fertility treatments, and a rising trend of delayed parenthood. For instance, an article published by National Center for Biotechnology and information (NCBI) in 2021, International Fertility Education Initiative (IFEI) mission is to improve fertility awareness and preconception health through public education and research. It aims to establish country-specific evidence about fertility awareness and evaluate the effectiveness of existing and emerging fertility education programs. Such initiatives taken by governments to spread awareness drive the IVF devices and consumables market growth.

In addition, advancements in assisted reproductive technologies (ART), coupled with a growing acceptance of IVF procedures, contribute significantly to market growth. The continuous development of innovative and technologically advanced devices, such as time-lapse incubators, embryo selection systems, and specialized micromanipulation tools, enhances the efficiency and success rates of IVF procedures, driving demand for IVF devices globally. Moreover, the expanding scope of fertility tourism, where individuals seek IVF treatments in different countries, further boosts the IVF devices market. Moreover high consumption of consumables also drives the IVF consumables market.

However, challenges include the high cost of IVF treatments and complications associated with IVF especially in underdeveloped economies may negatively impact the market growth. Despite these challenges, the market is poised for growth due to ongoing research, increased investments in healthcare infrastructure, and a rising global demand for fertility treatments, surge in utilization of consumables thus driving the IVF consumables market. Moreover, advancement in devices further drives the In-Vitro fertilization devices market.

A recession may lead to reduced demand and delayed purchases affects IVF devices market including pricing strategies, healthcare policies, and changes in consumer behavior, may influence the market dynamics. During a recession, individuals may face financial uncertainties, leading to a potential decline in the ability to invest in expensive fertility treatments like in vitro fertilization (IVF). Discretionary spending on elective medical procedures, such as assisted reproductive technologies, might be deprioritized as individuals prioritize essential needs. Additionally, healthcare budgets, both public and private, could be strained, impacting insurance coverage for fertility treatments, thus affecting IVF devices market.

Despite these challenges, the IVF devices and consumables market continues to experience moderate revenue growth owing to technological advancements in IVF procedures and surge in cases of infertility. Thus, the IVF devices and consumables market is moderately impacted by recession.

Segmental Overview

The IVF devices and consumables market analysis is segmented into product, technology, end user, and region. By product the market is categorized into instruments, accessories & disposables, and reagents & media. The instruments segment is further categorized into sperm separation systems, cryosystems, incubators, imaging systems, ovum aspiration pumps, cabinets, micromanipulators, and others. The reagents & media is sub segmented into cryopreservation media, semen processing media, ovum processing media, and embryo culture media.

By technology, the market is classified into fresh embryo IVF, frozen embryo IVF, and donor egg IVF. By end user, the market is classified into fertility clinics, hospitals, surgical centers, and clinical research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By Product

The accessories & disposables segment dominated the global IVF devices and consumables market share in 2022, owing to vital role of IVF accessories & disposables in every IVF procedure such as retrieval of oocytes, analysis & screening of sperms, and handling gametes. 

However, the instrument segment is expected to register the highest CAGR during the forecast period, owing to a rise in technological advancements in equipment, increased precision in fertility treatments, and surge in demand for sophisticated equipment. Moreover, advancement in devices further drives the In-Vitro fertilization devices market.

[PRODUCTGRAPH]

By Technology

The fresh embryo IVF segment dominated the global IVF devices and consumables market size in 2022, owing to higher success rates associated with fresh embryo transfers, increase in preference for single embryo transfer to reduce multiple pregnancy risks, and advancements in culture media & incubation technologies optimizing the conditions for fresh embryo development.

However, frozen embryo IVF segment is expected to register the highest CAGR during the forecast period, owing to flexibility and convenience offered by frozen embryo transfer and rising awareness of the potential benefits of frozen embryo transfer, such as improved pregnancy outcomes and reduced risks of complications which contribute to its rising popularity, thus boosting IVF devices market size.

[TECHNOLOGYGRAPH]

By End User

The fertility clinics segment held the largest global IVF devices and consumables market size in 2022 and is expected to register the highest CAGR during the forecast period, owing to availability of skilled medical professionals, advanced laboratory facilities, contribute to higher success rates in fertility treatments, rise in acceptance of assisted reproductive technologies (ART) as viable solutions and the pivotal role of fertility clinics offering comprehensive fertility services.

[ENDUSERGRAPH]

By Region

IVF devices and consumables industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for a major share of the IVF devices and consumables market in 2022 and is expected to register the highest CAGR during the forecast period. This is attributed to the increase in awareness about fertility treatments and acceptance of fertility treatments, coupled with changing socio-cultural norms, are contributing to a growing demand for IVF devices in the region. In addition, factors such as delayed parenthood, lifestyle changes, and a rise in infertility cases further fuel the adoption of IVF procedures.

Furthermore, growing healthcare infrastructure, advancements in medical technologies, and a surge in medical tourism for fertility treatments are enhancing accessibility to IVF procedures thereby propels the IVF devices market size. The increase in prevalence of reproductive health disorders and supportive government initiatives also play a pivotal role in fostering the expansion of the IVF devices and consumables market forecast in Asia-Pacific.

[REGIONGRAPH]

Competition Analysis

Competitive analysis and profiles of the major players in IVF devices and consumables market, such as Cook Group, Cooper Companies, Inc. Genea Limited, Fujifilm Holdings Corporation, Hamilton Thorne Ltd., Vitrolife AB, Esco Micro Pte. Ltd., Nidacon International AB, Kitazato Corporation, and Thermo Fisher Scientific, Inc. are provided in this report. Major players have adopted product launch, expansion, agreement, acquisition, and collaboration as key developmental strategies to improve the product portfolio of the IVF devices and consumables market and thus creates potential IVF devices and consumables market opportunity.

Recent Developments in the IVF Devices and Consumables Market

  • In July 2022, Esco Lifesciences Group announced the full acquisition of Evidence Solution, a Danish software company offering In Vitro Fertilization (IVF) management technologies and quality management systems.
  • In December 2021, Cooper Companies announced that it has completed the previously announced definitive purchase agreement to acquire Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue), for a purchase price of approximately $1.6 billion.
  • In January 2021, CooperSurgical, a leading provider of women's health care solutions, acquired Embryo Options, an established leader in cryo-storage software solutions for clinics and patients. This acquisition complements CooperSurgical's comprehensive portfolio of innovative fertility offerings.
  • In July 2023, Thermo Fisher Scientific launched two new next-generation sequencing-based options to support preimplantation genetic testing-aneuploidy (PGT-A) used commonly to inform in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) research. The Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit mark the first research use reproductive health assays available on the Ion Torrent Genexus Integrated Sequencer.
  • In July 2022, FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART) announced the launch of its Heavy Oil for Embryo Culture, a sterile mineral oil with an optimal weight viscosity that provides the ideal balance between ease of use and protection.
  • In May 2022, Cook Medical launched MINC+ Benchtop Incubator for IVF clinics in the U.S. and Canada. The MINC+ Benchtop Incubator is now available to clinical embryologists and IVF clinics in the U.S. and Canada.
  • In November 2020, Australian fertility innovator Genea Biomedx has entered into a collaboration agreement with Hamilton Thorne Ltd, a leading provider of products and services to the Assisted Reproductive Technologies markets. Under the terms of the collaboration agreement, Hamilton Thorne will exclusively commercialize and market Genea Biomedx flagship fertility technologies and products in the United States and Canada.
  • In December 2021, FUJIFILM Irvine Scientific, Inc., announced that its new manufacturing facility in Tilburg, the Netherlands is now open and fully operational. The facility provides state-of-the-art Life Science manufacturing and joins locations in the U.S. and Japan to enable increased production capacity of cell culture media products.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the IVF devices and consumables market analysis from 2022 to 2032 to identify the prevailing IVF devices and consumables market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and IVF devices and consumables industry opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the IVF devices and consumables market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global IVF devices industry.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global IVF devices and consumables market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By End User
    • Clinical Research Institutes
    • Fertility Clinics
    • Hospitals
    • Surgical Centers
  • By Product
    • Instruments
      • Type
        • Sperm Separation System
        • Cryosystem
        • Incubator
        • Imaging System
        • Ovum Aspiration Pump
        • Cabinet
        • Micromanipulator
        • Others
    • Accessories and Disposables
    • Reagents and Media
      • Type
        • Cryopreservation Media
        • Semen Processing Media
        • Ovum Processing Media
        • Embryo Culture Media
  • By Technology
    • Fresh Embryo IVF
    • Frozen Embryo IVF
    • Donor Egg IVF
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA


Key Market Players

  • Hamilton Thorne Ltd.
  • Cooper Companies, Inc.
  • Cook Group
  • Vitrolife AB
  • Thermo Fisher Scientific, Inc.
  • Esco Micro Pte. Ltd.
  • Fujifilm Holdings Corporation
  • Kitazato Corporation
  • Genea Limited
  • Nidacon International AB
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Moderate bargaining power of suppliers

      • 3.3.2. Moderate threat of new entrants

      • 3.3.3. Moderate threat of substitutes

      • 3.3.4. Moderate intensity of rivalry

      • 3.3.5. Moderate bargaining power of buyers

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Increase in infertility rates
        • 3.4.1.2. Delayed pregnancies among women
        • 3.4.1.3. Technological advancements in IVF devices
      • 3.4.2. Restraints

        • 3.4.2.1. High cost of IVF treatment
      • 3.4.3. Opportunities

        • 3.4.3.1. Growth opportunities in emerging markets
        • 3.4.3.2. Rise in number of fertility clinics
        • 3.4.3.3. Rise in trend of fertility tourism
  • CHAPTER 4: IVF DEVICES AND CONSUMABLES MARKET, BY PRODUCT

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Instruments

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

      • 4.2.4. Instruments IVF Devices and Consumables Market by Type

    • 4.3. Accessories and Disposables

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

    • 4.4. Reagents and Media

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis by country

      • 4.4.4. Reagents and Media IVF Devices and Consumables Market by Type

  • CHAPTER 5: IVF DEVICES AND CONSUMABLES MARKET, BY TECHNOLOGY

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Fresh Embryo IVF

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Frozen Embryo IVF

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Donor Egg IVF

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

  • CHAPTER 6: IVF DEVICES AND CONSUMABLES MARKET, BY END USER

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Fertility Clinics

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Hospitals

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Surgical Centers

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

    • 6.5. Clinical Research Institutes

      • 6.5.1. Key market trends, growth factors and opportunities

      • 6.5.2. Market size and forecast, by region

      • 6.5.3. Market share analysis by country

  • CHAPTER 7: IVF DEVICES AND CONSUMABLES MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key market trends, growth factors and opportunities

      • 7.2.2. Market size and forecast, by Product

      • 7.2.3. Market size and forecast, by Technology

      • 7.2.4. Market size and forecast, by End User

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Market size and forecast, by Product
          • 7.2.5.1.2. Market size and forecast, by Technology
          • 7.2.5.1.3. Market size and forecast, by End User
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Market size and forecast, by Product
          • 7.2.5.2.2. Market size and forecast, by Technology
          • 7.2.5.2.3. Market size and forecast, by End User
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Market size and forecast, by Product
          • 7.2.5.3.2. Market size and forecast, by Technology
          • 7.2.5.3.3. Market size and forecast, by End User
    • 7.3. Europe

      • 7.3.1. Key market trends, growth factors and opportunities

      • 7.3.2. Market size and forecast, by Product

      • 7.3.3. Market size and forecast, by Technology

      • 7.3.4. Market size and forecast, by End User

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Market size and forecast, by Product
          • 7.3.5.1.2. Market size and forecast, by Technology
          • 7.3.5.1.3. Market size and forecast, by End User
        • 7.3.5.2. France
          • 7.3.5.2.1. Market size and forecast, by Product
          • 7.3.5.2.2. Market size and forecast, by Technology
          • 7.3.5.2.3. Market size and forecast, by End User
        • 7.3.5.3. UK
          • 7.3.5.3.1. Market size and forecast, by Product
          • 7.3.5.3.2. Market size and forecast, by Technology
          • 7.3.5.3.3. Market size and forecast, by End User
        • 7.3.5.4. Italy
          • 7.3.5.4.1. Market size and forecast, by Product
          • 7.3.5.4.2. Market size and forecast, by Technology
          • 7.3.5.4.3. Market size and forecast, by End User
        • 7.3.5.5. Spain
          • 7.3.5.5.1. Market size and forecast, by Product
          • 7.3.5.5.2. Market size and forecast, by Technology
          • 7.3.5.5.3. Market size and forecast, by End User
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Market size and forecast, by Product
          • 7.3.5.6.2. Market size and forecast, by Technology
          • 7.3.5.6.3. Market size and forecast, by End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key market trends, growth factors and opportunities

      • 7.4.2. Market size and forecast, by Product

      • 7.4.3. Market size and forecast, by Technology

      • 7.4.4. Market size and forecast, by End User

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. Japan
          • 7.4.5.1.1. Market size and forecast, by Product
          • 7.4.5.1.2. Market size and forecast, by Technology
          • 7.4.5.1.3. Market size and forecast, by End User
        • 7.4.5.2. China
          • 7.4.5.2.1. Market size and forecast, by Product
          • 7.4.5.2.2. Market size and forecast, by Technology
          • 7.4.5.2.3. Market size and forecast, by End User
        • 7.4.5.3. India
          • 7.4.5.3.1. Market size and forecast, by Product
          • 7.4.5.3.2. Market size and forecast, by Technology
          • 7.4.5.3.3. Market size and forecast, by End User
        • 7.4.5.4. Australia
          • 7.4.5.4.1. Market size and forecast, by Product
          • 7.4.5.4.2. Market size and forecast, by Technology
          • 7.4.5.4.3. Market size and forecast, by End User
        • 7.4.5.5. South Korea
          • 7.4.5.5.1. Market size and forecast, by Product
          • 7.4.5.5.2. Market size and forecast, by Technology
          • 7.4.5.5.3. Market size and forecast, by End User
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Market size and forecast, by Product
          • 7.4.5.6.2. Market size and forecast, by Technology
          • 7.4.5.6.3. Market size and forecast, by End User
    • 7.5. LAMEA

      • 7.5.1. Key market trends, growth factors and opportunities

      • 7.5.2. Market size and forecast, by Product

      • 7.5.3. Market size and forecast, by Technology

      • 7.5.4. Market size and forecast, by End User

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Market size and forecast, by Product
          • 7.5.5.1.2. Market size and forecast, by Technology
          • 7.5.5.1.3. Market size and forecast, by End User
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Market size and forecast, by Product
          • 7.5.5.2.2. Market size and forecast, by Technology
          • 7.5.5.2.3. Market size and forecast, by End User
        • 7.5.5.3. South Africa
          • 7.5.5.3.1. Market size and forecast, by Product
          • 7.5.5.3.2. Market size and forecast, by Technology
          • 7.5.5.3.3. Market size and forecast, by End User
        • 7.5.5.4. Rest of LAMEA
          • 7.5.5.4.1. Market size and forecast, by Product
          • 7.5.5.4.2. Market size and forecast, by Technology
          • 7.5.5.4.3. Market size and forecast, by End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product mapping of top 10 player

    • 8.4. Competitive dashboard

    • 8.5. Competitive heatmap

    • 8.6. Top player positioning, 2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Cook Group

      • 9.1.1. Company overview

      • 9.1.2. Key executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

      • 9.1.6. Key strategic moves and developments

    • 9.2. Cooper Companies, Inc.

      • 9.2.1. Company overview

      • 9.2.2. Key executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

      • 9.2.6. Business performance

      • 9.2.7. Key strategic moves and developments

    • 9.3. Genea Limited

      • 9.3.1. Company overview

      • 9.3.2. Key executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

      • 9.3.6. Key strategic moves and developments

    • 9.4. Fujifilm Holdings Corporation

      • 9.4.1. Company overview

      • 9.4.2. Key executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

      • 9.4.6. Business performance

      • 9.4.7. Key strategic moves and developments

    • 9.5. Thermo Fisher Scientific, Inc.

      • 9.5.1. Company overview

      • 9.5.2. Key executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

      • 9.5.6. Business performance

      • 9.5.7. Key strategic moves and developments

    • 9.6. Vitrolife AB

      • 9.6.1. Company overview

      • 9.6.2. Key executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

      • 9.6.6. Business performance

    • 9.7. Hamilton Thorne Ltd.

      • 9.7.1. Company overview

      • 9.7.2. Key executives

      • 9.7.3. Company snapshot

      • 9.7.4. Operating business segments

      • 9.7.5. Product portfolio

      • 9.7.6. Business performance

    • 9.8. Esco Micro Pte. Ltd.

      • 9.8.1. Company overview

      • 9.8.2. Key executives

      • 9.8.3. Company snapshot

      • 9.8.4. Operating business segments

      • 9.8.5. Product portfolio

      • 9.8.6. Key strategic moves and developments

    • 9.9. Kitazato Corporation

      • 9.9.1. Company overview

      • 9.9.2. Key executives

      • 9.9.3. Company snapshot

      • 9.9.4. Operating business segments

      • 9.9.5. Product portfolio

    • 9.10. Nidacon International AB

      • 9.10.1. Company overview

      • 9.10.2. Key executives

      • 9.10.3. Company snapshot

      • 9.10.4. Operating business segments

      • 9.10.5. Product portfolio

  • LIST OF FIGURES

  • FIGURE 01. IVF DEVICES AND CONSUMABLES MARKET, 2022-2032
    FIGURE 02. SEGMENTATION OF IVF DEVICES AND CONSUMABLES MARKET,2022-2032
    FIGURE 03. TOP IMPACTING FACTORS IN IVF DEVICES AND CONSUMABLES MARKET (2022 TO 2032)
    FIGURE 04. TOP INVESTMENT POCKETS IN IVF DEVICES AND CONSUMABLES MARKET (2023-2032)
    FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
    FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
    FIGURE 07. MODERATE THREAT OF SUBSTITUTES
    FIGURE 08. MODERATE INTENSITY OF RIVALRY
    FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
    FIGURE 10. GLOBAL IVF DEVICES AND CONSUMABLES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 11. IVF DEVICES AND CONSUMABLES MARKET, BY PRODUCT, 2022 AND 2032(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF IVF DEVICES AND CONSUMABLES MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 13. COMPARATIVE SHARE ANALYSIS OF IVF DEVICES AND CONSUMABLES MARKET FOR ACCESSORIES AND DISPOSABLES, BY COUNTRY 2022 AND 2032(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF IVF DEVICES AND CONSUMABLES MARKET FOR REAGENTS AND MEDIA, BY COUNTRY 2022 AND 2032(%)
    FIGURE 15. IVF DEVICES AND CONSUMABLES MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
    FIGURE 16. COMPARATIVE SHARE ANALYSIS OF IVF DEVICES AND CONSUMABLES MARKET FOR FRESH EMBRYO IVF, BY COUNTRY 2022 AND 2032(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF IVF DEVICES AND CONSUMABLES MARKET FOR FROZEN EMBRYO IVF, BY COUNTRY 2022 AND 2032(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF IVF DEVICES AND CONSUMABLES MARKET FOR DONOR EGG IVF, BY COUNTRY 2022 AND 2032(%)
    FIGURE 19. IVF DEVICES AND CONSUMABLES MARKET, BY END USER, 2022 AND 2032(%)
    FIGURE 20. COMPARATIVE SHARE ANALYSIS OF IVF DEVICES AND CONSUMABLES MARKET FOR FERTILITY CLINICS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF IVF DEVICES AND CONSUMABLES MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 22. COMPARATIVE SHARE ANALYSIS OF IVF DEVICES AND CONSUMABLES MARKET FOR SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 23. COMPARATIVE SHARE ANALYSIS OF IVF DEVICES AND CONSUMABLES MARKET FOR CLINICAL RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
    FIGURE 24. IVF DEVICES AND CONSUMABLES MARKET BY REGION, 2022 AND 2032(%)
    FIGURE 25. U.S. IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 26. CANADA IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 27. MEXICO IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 28. GERMANY IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 29. FRANCE IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 30. UK IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 31. ITALY IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 32. SPAIN IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 33. REST OF EUROPE IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 34. JAPAN IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 35. CHINA IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 36. INDIA IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 37. AUSTRALIA IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 38. SOUTH KOREA IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 39. REST OF ASIA-PACIFIC IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 40. BRAZIL IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 41. SAUDI ARABIA IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 42. SOUTH AFRICA IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 43. REST OF LAMEA IVF DEVICES AND CONSUMABLES MARKET, 2022-2032 ($MILLION)
    FIGURE 44. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
    FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
    FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
    FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 48. COMPETITIVE DASHBOARD
    FIGURE 49. COMPETITIVE HEATMAP: IVF DEVICES AND CONSUMABLES MARKET
    FIGURE 50. TOP PLAYER POSITIONING, 2022
    FIGURE 51. COOPER COMPANIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 52. COOPER COMPANIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 53. COOPER COMPANIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 54. FUJIFILM HOLDINGS CORPORATION: NET REVENUE, 2021-2023 ($MILLION)
    FIGURE 55. FUJIFILM HOLDINGS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 56. FUJIFILM HOLDINGS CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 57. THERMO FISHER SCIENTIFIC, INC.: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 58. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 59. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 60. VITROLIFE AB: NET SALES, 2020-2022 ($MILLION)
    FIGURE 61. VITROLIFE AB: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 62. VITROLIFE AB: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 63. HAMILTON THORNE LTD.: NET SALES, 2020-2022 ($MILLION)

Purchase Full Report of
IVF Devices and Consumables Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue